BR112014030716A2 - fragmentos de fibronectina modificada ou variantes e usos dos mesmos - Google Patents

fragmentos de fibronectina modificada ou variantes e usos dos mesmos

Info

Publication number
BR112014030716A2
BR112014030716A2 BR112014030716A BR112014030716A BR112014030716A2 BR 112014030716 A2 BR112014030716 A2 BR 112014030716A2 BR 112014030716 A BR112014030716 A BR 112014030716A BR 112014030716 A BR112014030716 A BR 112014030716A BR 112014030716 A2 BR112014030716 A2 BR 112014030716A2
Authority
BR
Brazil
Prior art keywords
variants
fibronectin fragments
modified fibronectin
modified
fragments
Prior art date
Application number
BR112014030716A
Other languages
English (en)
Inventor
Chuang Woei-Jer
Chang Yung-Sheng
Original Assignee
Dcb Usa Llc
Univ Nat Cheng Kung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dcb Usa Llc, Univ Nat Cheng Kung filed Critical Dcb Usa Llc
Publication of BR112014030716A2 publication Critical patent/BR112014030716A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
BR112014030716A 2012-06-07 2013-06-07 fragmentos de fibronectina modificada ou variantes e usos dos mesmos BR112014030716A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261656671P 2012-06-07 2012-06-07
PCT/US2013/044699 WO2013185027A2 (en) 2012-06-07 2013-06-07 Modified fibronectin fragments or variants and uses thereof

Publications (1)

Publication Number Publication Date
BR112014030716A2 true BR112014030716A2 (pt) 2018-06-26

Family

ID=49712865

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014030716A BR112014030716A2 (pt) 2012-06-07 2013-06-07 fragmentos de fibronectina modificada ou variantes e usos dos mesmos

Country Status (14)

Country Link
US (1) US9969791B2 (pt)
EP (1) EP2859113A4 (pt)
JP (1) JP6297543B2 (pt)
KR (1) KR20150041619A (pt)
CN (1) CN104968796A (pt)
AU (1) AU2013271445B2 (pt)
BR (1) BR112014030716A2 (pt)
CA (1) CA2876135A1 (pt)
IL (1) IL236098A0 (pt)
IN (1) IN2015MN00027A (pt)
MX (1) MX2014015028A (pt)
SG (1) SG11201408163VA (pt)
TW (1) TWI580692B (pt)
WO (1) WO2013185027A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104968796A (zh) * 2012-06-07 2015-10-07 庄伟哲 经修饰纤维黏连蛋白片段或变体及其用途
WO2015103643A2 (en) * 2014-01-06 2015-07-09 The General Hospital Corporation Integrin antagonists
CA2990523C (en) * 2015-06-26 2023-01-24 Spiber Technologies Ab Cyclic rgd cell-binding motif and uses thereof
WO2017069627A1 (en) 2015-10-23 2017-04-27 Universiteit Twente Integrin binding peptides and uses thereof
WO2019165017A1 (en) * 2018-02-23 2019-08-29 The University Of Chicago Methods and composition involving thermophilic fibronectin type iii (fn3) monobodies
AU2019318538A1 (en) * 2018-08-08 2021-03-25 The General Hospital Corporation Polypeptide integrin antagonists
CN111285932B (zh) * 2018-12-10 2023-07-11 武汉禾元生物科技股份有限公司 一种从基因工程水稻种子中分离纯化重组人纤维连接蛋白的方法
CN113092772A (zh) * 2019-12-23 2021-07-09 首都医科大学附属北京世纪坛医院 尿液黏连蛋白亚组sa-2及其多肽片段在过敏性疾病中的应用
CN112941081B (zh) * 2021-04-16 2023-04-21 广州启点生物科技有限公司 一种纤连蛋白突变体及其制备方法与应用
US11723955B1 (en) 2022-05-13 2023-08-15 Allgenesis Biotherapeutics Inc. VEGFR fusion protein pharmaceutical composition
TWI836609B (zh) * 2022-09-16 2024-03-21 國立成功大學 纖維黏蛋白第iii型結構域衍生的蛋白質及其應用
CN117298257A (zh) * 2023-07-14 2023-12-29 杭州恩和生物科技有限公司 人纤连蛋白或其功能片段的用途、筛选方法和试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
US20050118661A1 (en) * 2002-01-21 2005-06-02 Helen Mardon Fibronectin variants and screening methods
AU2009234338B2 (en) * 2008-01-18 2014-07-24 Burnham Institute For Medical Research Methods and compositions related to internalizing RGD peptides
WO2012082950A2 (en) * 2010-12-14 2012-06-21 University Of Rochester Chimeric fibronectin matrix mimetics and uses thereof
CN104968796A (zh) * 2012-06-07 2015-10-07 庄伟哲 经修饰纤维黏连蛋白片段或变体及其用途

Also Published As

Publication number Publication date
EP2859113A4 (en) 2016-04-13
JP2015521588A (ja) 2015-07-30
TWI580692B (zh) 2017-05-01
KR20150041619A (ko) 2015-04-16
CN104968796A (zh) 2015-10-07
WO2013185027A2 (en) 2013-12-12
IN2015MN00027A (pt) 2015-10-16
MX2014015028A (es) 2015-08-06
AU2013271445A1 (en) 2015-01-22
US9969791B2 (en) 2018-05-15
SG11201408163VA (en) 2015-01-29
US20150218251A1 (en) 2015-08-06
EP2859113A2 (en) 2015-04-15
TW201412770A (zh) 2014-04-01
IL236098A0 (en) 2015-01-29
AU2013271445B2 (en) 2016-12-15
JP6297543B2 (ja) 2018-03-20
CA2876135A1 (en) 2013-12-12

Similar Documents

Publication Publication Date Title
BR112014030716A2 (pt) fragmentos de fibronectina modificada ou variantes e usos dos mesmos
BR112013021524A2 (pt) micro-organismos recombinantes e usos dos mesmos
BR112013007499A2 (pt) piridazinonas - métodos de criação e usos
BR112015002790A2 (pt) anticorpos asgpr e usos dos mesmos.
BR112013013167A2 (pt) inibidores de bromodomínio e usos dos mesmos
BR112014003774A2 (pt) inibidores de dyrk1 e usos dos mesmos
BR112013033098A2 (pt) inibidores de glicosidade seletivos e usos dos mesmos
BR112013029163A2 (pt) modulação quinase e indicações dos mesmos
BRPI1009455A2 (pt) anticorpos anti-c40 e usos dos mesmos
BR112015003354A2 (pt) composições e métodos de microcápsula
BR112014019825A2 (pt) Glicoengenharia quimioenzimática de anticorpos e fragmentos fc dos mesmos
BRPI1011404A2 (pt) mutantes e usos dos mesmos
BR112015003227A2 (pt) processos de clicoconjugação e composições
BR112015001459A2 (pt) anticorpos anti-kit e usos dos mesmos.
BR112014000055A2 (pt) polipeptídeos de fusão de relaxina e usos dos mesmos
BR112013009496A2 (pt) artigos absorventes e métodos de fabricação dos mesmos
DK3115372T3 (da) Målrettede terapeutiske lysosomale enzymfusionsproteiner og anvendelser deraf
BR112014027730A2 (pt) material, e material não tecido
BR112014012539A2 (pt) moléculas de ligação específicas para her3 e usos dessas
BR112013014235A2 (pt) anticorpos anti-ccr4 e usos dos mesmos
BR112012006501A2 (pt) polipeptídios e usos dos mesmos
BR112015009718A2 (pt) composição de matéria e artigo.
BR112013012563A2 (pt) bactéria recombinante e processo de elaboração de glicerol
BR112014000022A2 (pt) 1-3-tiazepinas ciclopropil-fundidas como inibidores de bace 1 e/ou bace 2
DK2809669T3 (da) Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]